Skip to content

Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases

Clinical Value of the Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05403216
Enrollment
150
Registered
2022-06-03
Start date
2022-12-01
Completion date
2024-12-31
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Lichen Planus

Brief summary

On the basis of previous studies, a validation cohort will be established to explore the relationship between oral lichen planus and autoimmune thyroid diseases, and a disease efficacy prediction strategy can be formed.

Detailed description

For oral lichen planus patients, the prevalence of Hashimoto's thyroiditis will be investigated and the relationship between levels of anti-TG, anti-TPO antibodies and severity of oral lichen planus will be determined. Besides, for patients with Hashimoto's thyroiditis, the prevalence of oral lichen planus will be investigated and the relationship between levels of anti-TG, anti-TPO antibodies and severity of oral lichen planus will be determined.

Interventions

OTHERno intervention

Sponsors

The Dental Hospital of Zhejiang University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* OLP patients without systemic disease

Exclusion criteria

* OLP patients with severe periodontal disease

Design outcomes

Primary

MeasureTime frameDescription
Oral lichen planus (OLP) lesions record1 yearRecord changes of lesions based on the symptoms and signs of the oral lichen planus patient.
Level of thyroid function and antibody1 yearThe levels of thyroid hormone and thyroid autoantibodies in serum of OLP patients were detected.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026